期刊文献+

驻极体氟尿嘧啶凝胶贴剂的制备研究

The preparation of electret fluorouracil gel patch
下载PDF
导出
摘要 目的制备并优化驻极体氟尿嘧啶凝胶贴剂及考察贴剂的相关性质。方法通过预实验筛选黏合剂和保湿剂,采用正交设计优化处方,用补偿法测量驻极体贴剂的电荷储存稳定性,用透皮扩散仪和HPLC仪研究药物的体外透皮作用。结果贴剂基质的最佳配比为PAAS∶明胶∶PVA∶高岭土∶CMC-Na∶保湿剂=0.2∶0.7∶0.5∶0.7∶0.2∶12;制备的贴剂具有良好的电荷储存稳定性;驻极体和3%氮酮均能有效地促进药物释放,且两者有协同促渗作用。结论按最佳条件制备了质量优良的驻极体氟尿嘧啶凝胶贴剂,该贴剂对皮肤无刺激性,且该贴剂的药物释放行为优于一般的凝胶贴剂。 Objective To study and optimize the preparation process and abserve the related properties of electret flu-orouracil gel patch .Methods the adhesives and moistening agents were screened by preliminary experiment .The optimal matrix proportion in the blank gel patch was obtained with orthogonal design .The charge storage stability of the patch was studied by compensation method .The transdermal behaviors of the patch were evaluated by modified diffusion cell method and HPLC .Results The optimal matrix proportions of PAAS ∶ gelatin ∶ PVA ∶ Kaolin ∶ CMC-Na ∶ moistening agents were 0 .2∶0 .7∶0 .5∶0 .7∶0 .2∶12 .The patch had a good charge storage stability .All the electrets and 3% azone could enhance the cumulative penetration amount of drug and they had synergistic enhancing effect .Conclusion The qualified electret fluorouracil gel patch was prepared under the optimal process ,which had no skin irritation and the behavior of transdermal de-livery was better than that of the traditional gel patch .
出处 《药学实践杂志》 CAS 2015年第3期217-220,共4页 Journal of Pharmaceutical Practice
基金 国家自然科学基金资助(51477175)
关键词 驻极体 氟尿嘧啶 凝胶贴剂 透皮吸收 electret fluorouracil gel patch transdermal delivery
  • 相关文献

参考文献4

二级参考文献29

  • 1郝秀华,程刚,王琳,文力奇,李岩,崔福德.中心复合设计优化5-氟尿嘧啶肝动脉栓塞微球的制备工艺[J].中国药学杂志,2004,39(7):525-527. 被引量:16
  • 2黄晋生,刘为纹,刘松青,房殿春,唐光哲.5-Fu佐剂包裹物的抗肿瘤作用的实验研究[J].肿瘤防治研究,1995,22(1):9-11. 被引量:4
  • 3SpectorT,镡旭民,石艳玲.5-氟尿嘧啶治疗活性的调节剂5-乙炔尿嘧啶[J].国外医学(药学分册),1995,22(2):102-105. 被引量:2
  • 4奚念朱.药剂学[M].北京:人民卫生出版社,1998.92-116.
  • 5Roullin VG, Mege M, Lemaire L,et al. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization [ J ]. Pharm Res, 2004, 21 ( 9 ):1558-1563.
  • 6Pohlen U, Reszka R, Schneider P, et al. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits[J ]. Anticancer Res ,2004, 24(3a): 1699-1704.
  • 7Pohlen U, Binnenhei M, Reszka R, et al. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value. An animal study in VX-2 liver tumor-bearing rabbits [ J ]. Chemotherapy,2004,50(2):67-75.
  • 8Krishnaiah YS, Satyanarayana V, Dinesh Kumar B. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets[J]. Eur J Pharm Sci,2003,19(5) :355-362.
  • 9张凤春,刘晓勇,陈云峰.氟尿嘧啶涂膜剂的研制[J].中国医院药学杂志,1997,17(8):363-364. 被引量:3
  • 10刘淑芝,汤亚池,费虹.中药巴布剂研究概况[J].国外医学(中医中药分册),1997,19(5):13-16. 被引量:33

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部